These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 4855448)

  • 1. 3. Drug regulations in Switzerland and their application.
    Hippenmeier F
    Bull Parenter Drug Assoc; 1974; 28(4):167-73. PubMed ID: 4855448
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug quality control work in Daru: observations during 1983-1986.
    Kibwage IO; Ogeto JO; Maitai CK; Rutere G; Thuranira J; Ochieng' A
    East Afr Med J; 1992 Oct; 69(10):577-80. PubMed ID: 1473513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QUAD routes out inferior drugs.
    Can Hosp; 1973 May; 50(5):58-9. PubMed ID: 4779804
    [No Abstract]   [Full Text] [Related]  

  • 4. [Standards imposed by the pharmacopoeia on drugs].
    Büchi J
    Pharm Acta Helv; 1972; 47(11):648-63. PubMed ID: 4657534
    [No Abstract]   [Full Text] [Related]  

  • 5. Legal aspects of regulations pertaining to sale and distribution of analytical standards for drugs of abuse. I.
    Evans JG
    J Chromatogr Sci; 1972 May; 10(5):342-6. PubMed ID: 5066301
    [No Abstract]   [Full Text] [Related]  

  • 6. WHO Expert Committee on specifications for pharmaceutical preparations.
    World Health Organization Expert Committee
    World Health Organ Tech Rep Ser; 2010; (957):1-276, back cover. PubMed ID: 20560300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Responsibility for drug testing and control].
    Büchi J
    Pharm Acta Helv; 1968 Sep; 43(9):619-27. PubMed ID: 5718866
    [No Abstract]   [Full Text] [Related]  

  • 8. Panel discussion: international drug regulations and their practical application. I. Swedish experience of drug regulations and their applications.
    Liljestrand A
    Bull Parenter Drug Assoc; 1974; 28(4):153-60. PubMed ID: 4853527
    [No Abstract]   [Full Text] [Related]  

  • 9. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organ Tech Rep Ser; 1999; 885():i-vi, 1-156. PubMed ID: 10352573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality control of drugs: certification scheme on the quality of pharmaceutical products moving in international commerce.
    WHO Chron; 1980 Nov; 34(11):427-32. PubMed ID: 7467274
    [No Abstract]   [Full Text] [Related]  

  • 11. WHO expert committee on specifications for pharmaceutical preparations. Fortieth report.
    WHO Expert Committee on Specifications for Pharmaceutical Preparations
    World Health Organ Tech Rep Ser; 2006; 937():1-461, back cover. PubMed ID: 16836287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current development in regulation of similar biotherapeutic products in Brazil.
    Castanheira LG; Barbano DB; Rech N
    Biologicals; 2011 Sep; 39(5):308-11. PubMed ID: 21868247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Counterfeit drugs: defining the problem and finding solutions.
    Wertheimer AI; Santella TM
    Expert Opin Drug Saf; 2005 Jul; 4(4):619-22. PubMed ID: 16011440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organ Tech Rep Ser; 2003; 917():i-viii, 1-125, back cover. PubMed ID: 15024913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Drug testing: progress and expectations].
    Aschenbrenner R; Lewandowski G
    Internist (Berl); 1973 Jan; 14(1):1-5. PubMed ID: 4576793
    [No Abstract]   [Full Text] [Related]  

  • 16. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organization
    World Health Organ Tech Rep Ser; 2005; 929():1-142, backcover. PubMed ID: 16353684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Control of drug quality].
    Castillio de Sánchez ML
    Salud Publica Mex; 1975; 17(4):525-30. PubMed ID: 1198274
    [No Abstract]   [Full Text] [Related]  

  • 18. New countermeasures considered as drug counterfeiting grows.
    Schubert C
    Nat Med; 2008 Jul; 14(7):700. PubMed ID: 18607355
    [No Abstract]   [Full Text] [Related]  

  • 19. Principles of drug regulations in Yugoslavia.
    Zlatic S; Vrhovac B
    Int J Clin Pharmacol; 1973 Apr; 7(2):180-2. PubMed ID: 4731285
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug product quality.
    Exp Med Surg; 1971; 29(1):135-44. PubMed ID: 5147595
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.